HALO

Halozyme Therapeutics
HALO

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$6.65B
EV
$7.44B
Shares Outstanding
125.47M
Beta
1.18

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$67.00
P/E 2025E
10.16x
P/Revenue 2025E
5.34x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Halozyme Therapeutics, Inc.

gainify
HALO

Halozyme Therapeutics, Inc.

HALO

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company’s products are based on the patented reco...

Sector

Healthcare

Industry

Biotechnology

CEO

Torley, Helen

Employees

350

IPO Date

2004-03-16

Headquarters

12390 El Camino Real, San Diego, California, 92130, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.